International, Peer Reviewed, Open Access Journal

Journal of Clinical Pharmacology and Therapeutics
(ISSN: 2766-8347)

Submit Manuscript

Journal of Clinical Pharmacology and Therapeutics

Journal of Clinical Pharmacology and Therapeutics is an open access peer reviewed journal which provides latest updates in treatments, advanced procedures, technologies associated within the field of Pharmacology and other related sub-divisions.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

Journal of Clinical Pharmacology and Therapeutics provide reports on optimal clinical use of various drugs and effects in treatment of patients.

Open Access - Journal of Clinical Pharmacology and Therapeutics

Editorial Board

Sana Irfan Khan - Journal of Clinical Pharmacology and Therapeutics

Sana Irfan Khan

Volunteering as a peer reviewer for submitted manuscripts
United States

Bruno Trimarco - Journal of Clinical Pharmacology and Therapeutics

Bruno Trimarco

Federico II University of Naples (www.unina.it)
Federico II University of Naples, Director of Division of Cardiology, Coronary care unit and Cat Lab Business or sector Medical

Italy

Athanasia Papazafiropoulou - Journal of Clinical Pharmacology and Therapeutics

Athanasia Papazafiropoulou

General Hospital of Piraeus “Tzaneio”, 1st Department of Internal Medicine
Greece

ÖMER ALKAN - Journal of Clinical Pharmacology and Therapeutics

ÖMER ALKAN

Associate professor in the department of econometrics
Turkey

Our Journal Indexed in

Articles

J Clin Pharmacol Ther. 2025;6(2):JCPT-06-1073 | Open Access

Death Edema Caused by Amlodipine Benazepril Tablets: A Case Report

Hui He, Yanping Gou, Xueying Bai and Di Shen

A 59-year-old man was treated with amlodipine benazepril tablets for hypertension. Perilabial edema occurred 24 hours after treatment and was not taken seriously. The next day, amlodipine Benazepril tablets were taken again and aggravated perilabial edema with laryngeal edema occurred. Considering the adverse reaction of amlodipine benazepril tablets, the drug was stopped immediately and the corresponding symptomatic treatment was given. After 10 ... Read more

CASE REPORT Updated Jun 07, 2025   PDF

J Clin Pharmacol Ther. 2025;6(2):JCPT-06-1072 | Open Access

Opinions on Avian Hyperuricemia and Gout Models: A Technical Comment

Zhijian Lin, Yu Wang, Xiaomeng Zhang and Bing Zhang

This technical comment discusses the value and challenges of avian models in the study of hyperuricemia and gout, highlighting their physiological similarities to humans and their potential for advancing biomedical research. The convergent evolution of uricase deficiency in avians and humans, makes these models particularly relevant for studying conditions like hyperuricemia and gout. The comment emphasizes the advantages of avian ... Read more

REVIEW ARTICLE Updated Jun 03, 2025   PDF

J Clin Pharmacol Ther. 2025;6(1):JCPT-06-1070 | Open Access

Two Anti-Glycation Agents from Flowers of Epiphyllum Oxypetalum (Dc.) Haw

Lingyu Li, Le Zhu, Mo Chen, Tianchen Yang, Ya Zhao and Zhiyu Shao

Background: Epiphyllum oxypetalum (DC.) Haw. is a plant of great ornamental value. In recent years, it has been gradually used in food and cosmetics, especially in cosmetics. Aims: Delve into the ingredients of E. Oxypetalum (DC.) Haw. to explore their beauty effects. Methods: The ingredients of E. Oxypetalum (DC.) Haw. were isolated and purified by HLB ... Read more

RESEARCH ARTICLE Updated May 03, 2025   PDF

J Clin Pharmacol Ther. 2025;6(1):JCPT-06-1069 | Open Access

Exploring Global Regulatory Pathways for Biosimilars in Advanced Therapeutic Areas

Vishal Rastogi, Riya Mahar, R1Amity Institute of Pharmacy, Indiaavi Maurya, Nithya Shanthi and Priyanka Saroj

Biosimilars are biologic drugs highly similar to an already approved reference biologic. They are transforming advanced therapeutic areas by increasing patient access to these drugs and lowering their costs. Guidelines for biosimilars have been established around the world but can be inconsistent and often reflect the inherent challenges associated with the adoption of biosimilars. For example, the first comprehensive biosimilar ... Read more

REVIEW ARTICLE Updated May 02, 2025   PDF

J Clin Pharmacol Ther. 2025;6(1):JCPT-06-1068 | Open Access

The Pharmacologic Basis for the Successful Treatment of Persistent Lyme Disease

Sam T Donta

 Lyme Disease is an infectious disease that may become a persistent illness. The causative organisms are sensitive in vitro to many antibiotics, but there are numerous patients with persisting symptoms that have had difficulty resolving those symptoms with standardly recommended antibiotic treatments. Herein is described the pharmacologic basis for the successful treatment of persistent Lyme disease, using ... Read more

REVIEW ARTICLE Updated Apr 17, 2025   PDF